March 18, 2008 - Northeast Monitoring Inc. released LX Sleep, a software product that reportedly detects OSA from data collected during a simplified, overnight, at-home, patient hookup to its OxyHolter product, as the company plans to launch its product line worldwide.

March 18, 2008 – The FDA gave AtriCure’s Coolrail linear ablation pen 510(k) clearance for the ablation of cardiac tissue, which can be used for patients with persistent and long-standing persistent atrial fibrillation, as the company expands its line of minimally invasive products.

March 18, 2008 - A catheter-based device, the Trellis-8 infusion catheter, which disperses thrombolytic solution directly into the clot of patients with deep vein thrombosis (DVT), is said to be safe and effective, according to data presented at the 33rd annual meeting of the Society of Interventional Radiology, held March 16, 2008.

March 18, 2008 - McKesson reports that it is unveiling two new Horizon Cardiology products for the cath lab, including Holding Area Charting and the Nurse Charting Station, at ACC ’08, both of which are designed to simplify and expedite information flow in the cath lab, increase data accuracy by minimizing duplication and strengthen the facility’s commitment to patient safety.

NorthEast Monitoring Inc. released LX Sleep, a software product that reportedly detects OSA from data collected during a simplified, overnight, at-home, patient hookup to its OxyHolter product.

Northeast Monitoring has introduced the DR200/HE, a combination 14-day Holter plus 30-day Event recorder integrated into a single unit that is designed for deployment to patients in either 'Holter' or 'Event' mode.

AtriCure’s Coolrail linear ablation pen for the ablation of cardiac tissue can be used for patients with persistent and long-standing persistent atrial fibrillation, according to the company, which provides minimally invasive products.

Bacchus Vascular Inc. has developed a catheter-based device, the Trellis-8 infusion catheter, which disperses thrombolytic solution directly into the clot of patients with deep vein thrombosis (DVT), is said to be safe and effective, according to data presented at the 33rd annual meeting of the Society of Interventional Radiology, held March 16, 2008.

McKesson has released a new Horizon Cardiology product for the cath lab, the Holding Area Charting, designed to simplify and expedite information flow in the cath lab, increase data accuracy by minimizing duplication and strengthen the facility’s commitment to patient safety.

The Society for Cardiovascular Angiography and Interventions (SCAI) has partnered with the American College of Cardiology (ACC) to co-locate its 33rd annual meeting with the ACC.08 57th Annual Scientific Session to form the new SCAI-ACCi2 meeting.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now